Mendel Money Management Has $5.15 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Mendel Money Management increased its stake in shares of Danaher Co. (NYSE:DHR) by 0.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,447 shares of the conglomerate’s stock after acquiring an additional 179 shares during the quarter. Danaher makes up about 2.3% of Mendel Money Management’s portfolio, making the stock its 9th largest position. Mendel Money Management’s holdings in Danaher were worth $5,153,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also bought and sold shares of DHR. Howard Capital Management Group LLC grew its stake in Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after acquiring an additional 48 shares during the period. Great Valley Advisor Group Inc. increased its stake in Danaher by 3.8% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 1,646 shares of the conglomerate’s stock valued at $458,000 after purchasing an additional 61 shares in the last quarter. Larson Financial Group LLC lifted its stake in shares of Danaher by 212.5% in the third quarter. Larson Financial Group LLC now owns 2,753 shares of the conglomerate’s stock valued at $765,000 after buying an additional 1,872 shares in the last quarter. Harvest Fund Management Co. Ltd grew its holdings in shares of Danaher by 544.6% during the third quarter. Harvest Fund Management Co. Ltd now owns 954 shares of the conglomerate’s stock valued at $265,000 after buying an additional 806 shares during the last quarter. Finally, DRW Securities LLC increased its position in shares of Danaher by 100.1% during the third quarter. DRW Securities LLC now owns 3,081 shares of the conglomerate’s stock worth $857,000 after acquiring an additional 1,541 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the subject of a number of recent research reports. Stifel Nicolaus raised Danaher from a “hold” rating to a “buy” rating and set a $260.00 price objective for the company in a report on Friday, March 14th. Royal Bank of Canada reissued an “outperform” rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Wells Fargo & Company cut their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Robert W. Baird lowered their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a report on Friday, December 13th. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $278.24.

Danaher Stock Down 0.2 %

Shares of DHR opened at $212.36 on Wednesday. The firm has a market cap of $151.78 billion, a P/E ratio of 40.22, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The stock has a 50 day simple moving average of $216.41 and a two-hundred day simple moving average of $237.75. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the company posted $2.09 EPS. On average, analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.60%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s dividend payout ratio (DPR) is presently 24.24%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.